Cite

HARVARD Citation

    RoismaN, L. et al. (2022). Crizotinib Restored Pembrolizumab Response in Advanced Non-Small Cell Lung Cancer. European journal of respiratory medicine. 4 (1), p. . [Online]. 
  
Back to record